Author:
Hirose Kosuke,Arita Yoh,Ogasawara Nobuyuki
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction;Hashimoto H;J Cardiovasc Pharmacol,1992
2. Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation);Atarashi H;Am J Cardiol,1996
3. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association;Antzelevitch C;Circulation,2005
4. Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction;Takabatake T;Eur J Clin Pharmacol,1991
5. A case of sinus pause due to the proarrhythmia of pilsicainide;Toeda T;Jpn Heart J,2000